Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Thomas R. Einarson, Basil G. Bereza, T. Anders Nielsen, Jan Van Laer & Michiel E. H. Hemels. (2016) Systematic review of models used in economic analyses in moderate-to-severe asthma and COPD. Journal of Medical Economics 19:4, pages 319-355.
Read now
Read now
Yevgeniy Samyshkin, Michael Schlunegger, Susan Haefliger, Sabine Ledderhose & Matthew Radford. (2013) Cost-effectiveness of roflumilast in combination with bronchodilator therapies in patients with severe and very severe COPD in Switzerland. International Journal of Chronic Obstructive Pulmonary Disease 8, pages 79-87.
Read now
Read now
Kristian Thorlund & Edward Mills. (2012) Stability of additive treatment effects in multiple treatment comparison meta-analysis: a simulation study. Clinical Epidemiology 4, pages 75-85.
Read now
Read now
Nadine Hertel, Robert W Kotchie, Yevgeniy Samyshkin, Matthew Radford, Samantha Humphreys & Kevin Jameson. (2012) Cost-effectiveness of available treatment options for patients suffering from severe COPD in the UK: a fully incremental analysis. International Journal of Chronic Obstructive Pulmonary Disease 7, pages 183-199.
Read now
Read now
Articles from other publishers (34)
Augustine Wigle & Audrey Béliveau. (2022) Bayesian unanchored additive models for component network meta‐analysis. Statistics in Medicine 41:22, pages 4444-4466.
Crossref
Crossref
Hélène Salvator, Emmanuel Naline, Marion Brollo, Hermann Tenor, Stanislas Grassin‐Delyle & Philippe Devillier. (2020) Clinical relevance of the relaxant effects of roflumilast on human bronchus: potentiation by a long‐acting beta‐2‐agonist. Fundamental & Clinical Pharmacology 35:4, pages 725-731.
Crossref
Crossref
Ahmed Salem, Heng Zhong, Mafalda Ramos, Mark Lamotte & Hao Hu. (2021) Potential clinical and economic impact of optimised maintenance therapy on discharged patients with COPD after hospitalisation for an exacerbation in China. BMJ Open 11:4, pages e043664.
Crossref
Crossref
Maria Petropoulou, Orestis Efthimiou, Gerta Rücker, Guido Schwarzer, Toshi A. Furukawa, Alessandro Pompoli, Huiberdina L. Koek, Cinzia Del Giovane, Nicolas Rodondi & Dimitris Mavridis. (2021) A review of methods for addressing components of interventions in meta-analysis. PLOS ONE 16:2, pages e0246631.
Crossref
Crossref
Hélène Salvator, Amparo Buenestado, Marion Brollo, Emmanuel Naline, Tatiana Victoni, Elisabeth Longchamp, Hermann Tenor, Stanislas Grassin-Delyle & Philippe Devillier. (2020) Clinical Relevance of the Anti-inflammatory Effects of Roflumilast on Human Bronchus: Potentiation by a Long-Acting Beta-2-Agonist. Frontiers in Pharmacology 11.
Crossref
Crossref
Eleanor L Axson, Adam Lewis, James Potts, Marie Pang, Scott Dickinson, Helene Vioix & Jennifer K Quint. (2020) Inhaled therapies for chronic obstructive pulmonary disease: a systematic review and meta-analysis. BMJ Open 10:9, pages e036455.
Crossref
Crossref
Gerta Rücker, Maria Petropoulou & Guido Schwarzer. (2019) Network meta‐analysis of multicomponent interventions. Biometrical Journal 62:3, pages 808-821.
Crossref
Crossref
Stefan Andreas, Christian Röver, Judith Heinz, Sebastian Straube, Henrik Watz & Tim Friede. (2019) Decline of COPD exacerbations in clinical trials over two decades – a systematic review and meta-regression. Respiratory Research 20:1.
Crossref
Crossref
Shaonan Liu, Jing Chen, Jinhong Zuo, Jiaqi Lai, Lei Wu & Xinfeng Guo. (2019) Comparative effectiveness of six Chinese herb formulas for acute exacerbation of chronic obstructive pulmonary disease: a systematic review and network meta-analysis. BMC Complementary and Alternative Medicine 19:1.
Crossref
Crossref
Suzanne C. Freeman, Neil W. Scott, Rachael Powell, Marie Johnston, Alex J. Sutton & Nicola J. Cooper. (2018) Component network meta-analysis identifies the most effective components of psychological preparation for adults undergoing surgery under general anesthesia. Journal of Clinical Epidemiology 98, pages 105-116.
Crossref
Crossref
Henrik Svedsater, Gillian Stynes, Jaro Wex, Lucy Frith, David Leather, Emanuela Castelnuovo, Michelle Detry & Scott Berry. (2016) Once-daily fluticasone furoate/vilanterol versus twice daily combination therapies in asthma–mixed treatment comparisons of clinical efficacy. Asthma Research and Practice 2:1.
Crossref
Crossref
Marc Miravitlles, Anthony D’Urzo, Dave Singh & Vladimir Koblizek. (2016) Pharmacological strategies to reduce exacerbation risk in COPD: a narrative review. Respiratory Research 17:1.
Crossref
Crossref
Christian Röver, Stefan Andreas & Tim Friede. (2016) Evidence synthesis for count distributions based on heterogeneous and incomplete aggregated data. Biometrical Journal 58:1, pages 170-185.
Crossref
Crossref
Gillian Stynes, Henrik Svedsater, Jaro Wex, Sally Lettis, David Leather, Emanuela Castelnuovo, Michelle Detry & Scott Berry. (2015) Once-daily fluticasone furoate/vilanterol 100/25 mcg versus twice daily combination therapies in COPD – mixed treatment comparisons of clinical efficacy. Respiratory Research 16:1.
Crossref
Crossref
Andrea C Tricco, Lisa Strifler, Areti-Angeliki Veroniki, Fatemeh Yazdi, Paul A Khan, Alistair Scott, Carmen Ng, Jesmin Antony, Kelly Mrklas, Jennifer D'Souza, Roberta Cardoso & Sharon E Straus. (2015) Comparative safety and effectiveness of long-acting inhaled agents for treating chronic obstructive pulmonary disease: a systematic review and network meta-analysis. BMJ Open 5:10, pages e009183.
Crossref
Crossref
Xin-Wei WangYan-Lin ZhangYing Xiong. (2015)
Impact of
ABCB1
Single-Nucleotide Polymorphisms on Treatment Outcomes with Salmeterol/Fluticasone Combination Therapy for Stable Chronic Obstructive Pulmonary Disease
. Genetic Testing and Molecular Biomarkers 19:10, pages 566-572.
Crossref
Crossref
Clary J. Foote, Harman Chaudhry, Mohit Bhandari, Lehana Thabane, Toshi A. Furukawa, Brad Petrisor & Gordon Guyatt. (2015) Network Meta-analysis: Users’ Guide for Surgeons: Part I - Credibility. Clinical Orthopaedics & Related Research 473:7, pages 2166-2171.
Crossref
Crossref
Mohsen Sadatsafavi, Carlo Marra, Shawn Aaron & Stirling Bryan. (2014) Incorporating external evidence in trial-based cost-effectiveness analyses: the use of resampling methods. Trials 15:1.
Crossref
Crossref
Zafar Zafari, Kristian Thorlund, J. Mark FitzGerald, Carlo A. Marra & Mohsen Sadatsafavi. (2014) Network vs. Pairwise Meta-Analyses: A Case Study of the Impact of an Evidence-Synthesis Paradigm on Value of Information Outcomes. PharmacoEconomics 32:10, pages 995-1004.
Crossref
Crossref
Yevgeniy Samyshkin, Robert W. Kotchie, Ann-Christin Mörk, Andrew H. Briggs & Eric D. Bateman. (2013) Cost-effectiveness of roflumilast as an add-on treatment to long-acting bronchodilators in the treatment of COPD associated with chronic bronchitis in the United Kingdom. The European Journal of Health Economics 15:1, pages 69-82.
Crossref
Crossref
Melissa Lipari, Harpreet Benipal & Pramodini Kale-Pradhan. (2013) Roflumilast in the management of chronic obstructive pulmonary disease. American Journal of Health-System Pharmacy 70:23, pages 2087-2095.
Crossref
Crossref
Pablo Alonso-Coello, David Rigau, Andrea Juliana Sanabria, Vicente Plaza, Marc Miravitlles & Laura Martinez. (2013) Calidad y fuerza: el sistema GRADE para la formulación de recomendaciones en las guías de práctica clínica. Archivos de Bronconeumología 49:6, pages 261-267.
Crossref
Crossref
Pablo Alonso-Coello, David Rigau, Andrea Juliana Sanabria, Vicente Plaza, Marc Miravitlles & Laura Martinez. (2013) Quality and Strength: The GRADE System for Formulating Recommendations in Clinical Practice Guidelines. Archivos de Bronconeumología (English Edition) 49:6, pages 261-267.
Crossref
Crossref
Anne C. Melzer, Laura M. Feemster, Jane E. Uman, David H. Ramenofsky & David H. Au. (2012) Missing Potential Opportunities to Reduce Repeat COPD Exacerbations. Journal of General Internal Medicine 28:5, pages 652-659.
Crossref
Crossref
A. Arnedillo Muñoz. (2013) Consenso sobre atención integral de las agudizaciones de la enfermedad pulmonar obstructiva crónica (ATINA-EPOC). Parte VI. SEMERGEN - Medicina de Familia 39:2, pages 85-88.
Crossref
Crossref
Saifee Rashiq, Ben Vandermeer, Ahmed M. Abou-Setta, Lauren A. Beaupre, C. Allyson Jones & Donna M. Dryden. (2013) Efficacy of supplemental peripheral nerve blockade for hip fracture surgery: multiple treatment comparisonEfficacité d’un bloc nerveux périphérique supplémentaire pour les chirurgies de fracture de la hanche: Comparaison de plusieurs traitements. Canadian Journal of Anesthesia/Journal canadien d'anesthésie 60:3, pages 230-243.
Crossref
Crossref
Edward J. Mills, Kristian Thorlund & John P.A. Ioannidis. (2012) Calculating additive treatment effects from multiple randomized trials provides useful estimates of combination therapies. Journal of Clinical Epidemiology 65:12, pages 1282-1288.
Crossref
Crossref
Luis M. Blasco. (2012) Alternativas para la indicación de roflumilast y la clasificación de enfermedad pulmonar obstructiva crónica. Archivos de Bronconeumología 48:9, pages 343.
Crossref
Crossref
Luis M. Blasco. (2012) Alternatives to Indicating Roflumilast and the Chronic Obstructive Pulmonary Disease Classification. Archivos de Bronconeumología (English Edition) 48:9, pages 343.
Crossref
Crossref
Leandro Lindner, Julio Ancochea, Jesús Aparicio & Leticia Camíns. (2013) Coste-efectividad de roflumilast en el tratamiento de pacientes con enfermedad pulmonar obstructiva crónica en España. PharmacoEconomics Spanish Research Articles 9:3, pages 95-108.
Crossref
Crossref
Maisha L. Kelly Freeman. (2012) Clinical Considerations for Roflumilast: A New Treatment for COPD. The Consultant Pharmacist 27:3, pages 189-193.
Crossref
Crossref
. (2012) Anexo 2 Preguntas respondidas por la UETS en la GPC para el tratamiento de pacientes con EPOC. Archivos de Bronconeumología 48, pages 61-80.
Crossref
Crossref
Milo Puhan. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
David Tovey. (2010) The Cochrane Library is changing. Cochrane Database of Systematic Reviews.
Crossref
Crossref